podophyllotoxin has been researched along with Leiomyosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnet, F; Cany, L; Coindre, JM; de Mascarel, A; Robert, J; Vergier, B | 1 |
| Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP | 1 |
| Hansen, HH; Muggia, FM; Selawry, OS | 1 |
2 trial(s) available for podophyllotoxin and Leiomyosarcoma
| Article | Year |
|---|---|
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms | 1975 |
Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819).
Topics: Aged; Antineoplastic Agents; Astrocytoma; Clinical Trials as Topic; Esophageal Neoplasms; Evaluation Studies as Topic; Fibroblasts; Glycosides; Humans; Hypotension; Lactones; Leiomyosarcoma; Leukopenia; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Mitosis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Structure-Activity Relationship; Thiophenes; Thrombocytopenia | 1971 |
1 other study(ies) available for podophyllotoxin and Leiomyosarcoma
| Article | Year |
|---|---|
Expression of MDR1/P glycoprotein in human sarcomas.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Carrier Proteins; Dactinomycin; Drug Resistance; Gene Expression; Hemangiosarcoma; Histiocytoma, Benign Fibrous; Histocytochemistry; Humans; Immunoblotting; In Situ Hybridization; Leiomyosarcoma; Liposarcoma; Membrane Glycoproteins; Neoplasm Proteins; Podophyllotoxin; Rhabdomyosarcoma; RNA, Messenger; RNA, Neoplasm; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Tumor Cells, Cultured; Vinca Alkaloids | 1993 |